# Targeted Lipidomics and Lipid Metabolism Elucidate Anti-Obesity Effects of Lactic Acid Bacteria-Fermented Purple Sweet Potato Tainung No. 73 Extract in Obese Mice

**Authors:** Hsien-Yi Yang, Chien-Hsun Huang, Shang-Tse Ho, Hsin-Hui Su, Yen-Po Chen, Yung-Tsung Chen

PMC · DOI: 10.3390/ijms27031489 · International Journal of Molecular Sciences · 2026-02-03

## TL;DR

Fermenting purple sweet potato with lactic acid bacteria improves its ability to reduce obesity and related health issues in mice.

## Contribution

The study shows that lactic acid bacteria fermentation enhances purple sweet potato's anti-obesity effects through lipid metabolism modulation.

## Key findings

- Fermented sweet potato extract reduced body weight gain and fat accumulation in obese mice.
- The extract improved serum lipid profiles and downregulated genes linked to fat and inflammation.
- Lipidomic analysis showed modulation of ceramides and acylcarnitines, key lipids in metabolic health.

## Abstract

The increasing prevalence of obesity and metabolic disorders poses a major global health challenge. In the present study, purple sweet potato Tainung No. 73 was fermented using Lactobacillus amylovorus OFMLa-73 and Levilactobacillus brevis OFMLb-143 to enrich the specific bioactive metabolite indolelactic acid. Furthermore, supplementation with fermented sweet potato (FSPE) ethanol extract resulted in a significant reduction in body weight gain, adipocyte hypertrophy, and hepatic lipid accumulation, while also improving serum lipid profiles in high-fat diet-induced obesity mice. These physiological improvements were associated with the downregulated expression of adipogenic and inflammatory genes in both liver and adipose tissues. Furthermore, lipidomic analysis revealed that FSPE modulated key lipid species, including ceramides and acylcarnitines, which are implicated in metabolic dysfunction. Collectively, these findings demonstrated that lactic acid fermentation enhanced purple sweet potato’s functional potential, positioning FSPE as a promising candidate for dietary intervention in obesity management.

## Linked entities

- **Chemicals:** indolelactic acid (PubChem CID 92904)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** Obesity (MESH:D009765), weight gain (MESH:D015430), inflammatory (MESH:D007249), metabolic disorders (MESH:D008659), adipocyte hypertrophy (MESH:D006984)
- **Chemicals:** ceramides (MESH:D002518), Lactic Acid (MESH:D019344), fat (MESH:D005223), FSPE (-), Lipid (MESH:D008055), indolelactic acid (MESH:C024139), acylcarnitines (MESH:C116917)
- **Species:** Solanum tuberosum (potatoes, species) [taxon 4113], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898302/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898302/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898302/full.md

---
Source: https://tomesphere.com/paper/PMC12898302